Mezera · DIN 02524481 · 500 mg · DR tablet
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Mezera · DIN 02524481
Manufacturer: Avir Pharma Inc.; listing date 2024-01-31
Health Canada: Marketed since 2022-10-05 · brand MEZERA · ATC A07EC02 MESALAZINE · form Tablet (delayed-release) · route Oral · ingredients MESALAZINE 500 MG · company Avir pharma inc. · schedule Prescription
Mezera: Formulary list price $0.68 per unit (the source does not state the unit; exact figure $0.6760). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02524481)
Source record
DIN 02524481: Mezera
Raw flags: sec3=Y
Item: 564000139; group id 672; item number 1671; lccId None; manufacturer id AVP
Source form: DR Tab; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $0.6760; ministry $0.6760
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02524481
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101350
Shortage status: not checked (no credentials)